These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13295081)

  • 1. The L. E. cell as a manifestation of delayed hydralazine intoxication.
    COMENS P; SCHROEDER HA
    J Am Med Assoc; 1956 Mar; 160(13):1134-6. PubMed ID: 13295081
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute systemic lupus erythematosus syndrome from hydralazine hydrochloride.
    HENN MJ; PARKIN TW; HARGRAVES MM; ODEL HM
    AMA Arch Intern Med; 1955 Jun; 95(6):857-62. PubMed ID: 14375421
    [No Abstract]   [Full Text] [Related]  

  • 3. Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy.
    SHACKMAN NH; SWILLER AI; MORRISON M
    J Am Med Assoc; 1954 Aug; 155(17):1492-4. PubMed ID: 13183773
    [No Abstract]   [Full Text] [Related]  

  • 4. Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy.
    REINHARDT DJ; WALDRON JM
    J Am Med Assoc; 1954 Aug; 155(17):1491-2. PubMed ID: 13183772
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute lupus erythematosus and hydralazine].
    TOURAINE RL
    Ann Dermatol Syphiligr (Paris); 1956; 83(2):158-66. PubMed ID: 13327372
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental hydralazine disease and its similarity to disseminated lupus erythematosus.
    COMENS P
    J Lab Clin Med; 1956 Mar; 47(3):444-54. PubMed ID: 13295709
    [No Abstract]   [Full Text] [Related]  

  • 7. Late systemic complications of hydralazine (apresoline) therapy.
    MULLER JC; RAST CL; PRYOR WW; ORGAIN ES
    J Am Med Assoc; 1955 Mar; 157(11):894-9. PubMed ID: 13233047
    [No Abstract]   [Full Text] [Related]  

  • 8. Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
    KLAYMAN MI; SILBERG NR; KARLEN WS
    N Engl J Med; 1953 Jun; 248(26):1109-11. PubMed ID: 13054899
    [No Abstract]   [Full Text] [Related]  

  • 9. Syndrome simulating collagen disease caused by hydralazine (Apresoline).
    PERRY HM; SCHROEDER HA
    J Am Med Assoc; 1954 Feb; 154(8):670-3. PubMed ID: 13117684
    [No Abstract]   [Full Text] [Related]  

  • 10. Rheumatic and febrile syndrome during prolonged hydralazine treatment.
    DUSTAN HP; TAYLOR RD; CORCORAN AC
    J Am Med Assoc; 1954 Jan; 154(1):23-9. PubMed ID: 13108653
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute psychosis as a complication of hydralazine therapy in essential hypertension.
    MOSER M; SYNER J; MALITZ S; MATTINGLY TW
    J Am Med Assoc; 1953 Aug; 152(14):1329-31. PubMed ID: 13061271
    [No Abstract]   [Full Text] [Related]  

  • 12. Arthralgia, headache, prostration, and fever during hydralazine therapy.
    SLONIM NB
    J Am Med Assoc; 1954 Apr; 154(17):1419. PubMed ID: 13151868
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding peptic ulcer complicating hydralazine and hexamethonium bromide therapy.
    MANDELBAUM H; BROOK J; MANDELBAUM RA
    J Am Med Assoc; 1954 Jun; 155(9):833-5. PubMed ID: 13162812
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic effects of 1-hydrazinophthalazine in ambulatory hypertensive patients.
    WALD MH; FIERRO MI; KEETON KH
    Am Heart J; 1953 Dec; 46(6):861-4. PubMed ID: 13104328
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal reaction to 1-hydrazinophthalazine (apresoline).
    COHEN BM
    Am Heart J; 1953 Jun; 45(6):931-5. PubMed ID: 13050605
    [No Abstract]   [Full Text] [Related]  

  • 16. Apresoline intolerance with bladder paralysis.
    Laurence DR; Miles NA
    N Engl J Med; 1953 Mar; 248(11):464-5. PubMed ID: 13036976
    [No Abstract]   [Full Text] [Related]  

  • 17. Pancytopenia following use of hydrallazine (apresoline).
    KAUFMAN M
    J Am Med Assoc; 1953 Apr; 151(17):1488-90. PubMed ID: 13034502
    [No Abstract]   [Full Text] [Related]  

  • 18. DISSEMINATED LUPUS ERYTHEMATOSUS IN A 28-MONTH-OLD INFANT WITH ONSET DURING HYDRALAZINE THERAPY.
    DEMARCO P; SHOHOV P; KRESKY B; ZAINO EC
    Clin Pediatr (Phila); 1964 May; 3():308-10. PubMed ID: 14129517
    [No Abstract]   [Full Text] [Related]  

  • 19. Late reaction to hydralazine (Apresoline) therapy.
    MANTER WB
    N Engl J Med; 1954 May; 250(19):835-6. PubMed ID: 13165907
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of anti-hydralazine antibody in hydralazine induced lupus erythematosus.
    FRIEDMAN H; HEINE WI
    Experientia; 1963 Jan; 19():10-1. PubMed ID: 13959802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.